Wells Fargo sees 2% quarterly drop in US Medicaid enrollment By Investing.com

Brent crude jumped ~7% and WTI topped $110/bbl amid Iran escalation signals and Hormuz uncertainty. Separately, Wells Fargo reports total Medicaid enrollment is tracking toward a 2% quarterly decline (expansion enrollment down ~1% q/q) with monthly drops of 0.8% in Jan, 0.7% in Feb and 0.5% in Mar; California is tracking a ~3% q/q decline vs a 1.3% drop in Q4 2025. Wells Fargo warns stricter eligibility verification is degrading the Medicaid risk pool and increasing acuity, while an Urban Institute study projects potential enrollment losses of 4.9M–10.1M under new work-requirement/redetermination scenarios.

Analysis

Administrative-driven churn from tightened eligibility checks will act like a surgical cut to the low-acuity end of the Medicaid pool, concentrating spend on costlier members and raising per-capita utilization metrics. Because capitation and state rate-setting are annual and backward-looking, managed-care plans will absorb a wave of higher acuity before rates reset — pressuring margins for multiple quarters even if total membership falls.

Hospitals and long-term care providers will see two offsetting forces: higher average revenue per treated patient from increased acuity, but also a rise in uncompensated-care volatility where coverage is lost abruptly. Specialty providers (behavioral health, substance-use, post-acute rehab) are likely to see demand that is both stickier and higher-margin, while community hospitals and rural nursing homes — with large Medicaid mixes and weak negotiating leverage — face budgetary squeezes.

At the state level, short-term fiscal “savings” from enrollment reductions can backfire via higher per-enrollee cost and political pressure to restore coverage or increase supplemental payments; that creates a 12–24 month window of policy risk and rate renegotiation. Key catalysts that could reverse the technical trend are court injunctions, CMS guidance easing redeterminations, administrative automation that reduces non-response, or a macro downturn that re-expands eligibility—each operates on different timebands (days-weeks for litigation, months for automation, quarters for macro).

Positioning should therefore separate short-term administrative pain (one-off margin compression) from longer-term structural winners and losers: favor providers that capture acuity-driven revenue and can reprice quickly, hedge or avoid pure-play Medicaid administrators until rate pass-through visibility improves.

Key Decisions for Investors

• Pair trade (3–12 months): Long Acadia Healthcare (ACHC) / Short Community Health Systems (CYH). Rationale: behavioral-health and specialized post-acute operators should capture higher acuity and utilization growth while community hospitals with heavy Medicaid mixes face reimbursement pressure. Target entry: initiate 3–5% of book pair exposure; look to capture 25–50% relative outperformance; tighten or cut if state supplemental payments are announced.
• Hedge managed-care exposure (3–9 months): Buy 3–6 month puts on Centene (CNC) sized to ~20% notional of Medicaid exposure. Centene is first-order exposed to enrollment churn and capitation lag; puts (10–15% OTM) offer asymmetric protection if acuity-driven costs compress margins before rate resets. Risk: litigation or emergency rate adjustments could reprice puts rapidly.
• Long selective hospital operator (6–12 months): Long HCA Healthcare (HCA) — lower Medicaid share, pricing leverage in urban markets. Size 3–6% of portfolio; expected to outperform peers by 15–30% if acuity-driven revenue per admission rises. Monitor for state payment cuts which would blunt upside.
• Opportunistic (12–24 months): Screen for state-level rate filings and MCO renewal decisions. When states begin upward rate adjustments (typical 12–18 month lag), rotate into underpriced MCOs that lost membership but can reprice (look for two positive quarters of adjusted EBITDA before adding). Execute with calendar spreads to exploit timing uncertainty.